Department of Old Age Psychiatry, Academic Sciences Division, Institute of Psychiatry, Psychology and Neurosciences, London, United Kingdom; Psychiatry for Elderly, Department of Health Sciences, College of Life Sciences, George Davies Centre, Leicester, United Kingdom.
Leicestershire Partnership NHS Trust, Leicester, United Kingdom; Department of Health Sciences, College of Life Sciences, George Davies Centre, Leicester, United Kingdom.
J Am Med Dir Assoc. 2020 Nov;21(11):1735-1739. doi: 10.1016/j.jamda.2020.05.016. Epub 2020 Jul 4.
Early-onset Alzheimer's disease (EOAD), defined as onset of AD before the age of 65 years, is less common than the late-onset type, and little is known about the factors affecting disease progression. The aim of the study was to investigate factors influencing disease progression in people with EOAD.
Retrospective cohort study.
People with EOAD who were assessed and attended the specialist memory service at a university teaching hospital in a European setting, between 2000 and 2010.
Sociodemographic details and clinical and cognitive assessments at initial assessment were used as potential predictors of change in clinical status and outcome at final follow-up within the memory service.
Of the 101 people diagnosed with EOAD during this period, 96 patients were followed up (53 women; aged 59 ± 4.9 years; mean follow-up 36.3 ± 29.12 months). Patients were classified as Stable (n = 25) if continued within the memory service or discharged to primary care, and those transferred to other specialist services (n = 66) for further inputs, institutional care (n = 4), or died (n = 1) were classified as Worseners (n = 71). Lower education (P = .008), lower Cambridge Cognition Examination scores (P = .049), and presence of family history of dementia [P = .012, χ (1) = 8.84] was associated with worse change in clinical status. Furthermore, cognitive deficits such as lower scores on comprehension, recent memory, and executive functions were found to predict a worse clinical outcome.
Identification of predictors of faster disease progression has significant clinical benefit, allowing clinicians to estimate prognosis and plan patient care accordingly.
早发性阿尔茨海默病(EOAD)定义为 65 岁以前发病的 AD,比晚发性 AD 少见,对影响疾病进展的因素知之甚少。本研究旨在探讨影响 EOAD 患者疾病进展的因素。
回顾性队列研究。
2000 年至 2010 年期间,在欧洲一所大学教学医院的专科记忆服务中心接受评估和就诊的 EOAD 患者。
初始评估时的社会人口统计学详细信息以及临床和认知评估,被用作记忆服务最终随访时临床状况和结局变化的潜在预测因素。
在此期间诊断为 EOAD 的 101 例患者中,有 96 例得到了随访(53 例女性;年龄 59±4.9 岁;平均随访 36.3±29.12 个月)。如果患者继续在记忆服务中心或出院至初级保健中心,则将其归类为稳定(n=25),而那些转至其他专科服务(n=66)、机构护理(n=4)或死亡(n=1)的患者则归类为恶化(n=71)。较低的教育程度(P=0.008)、较低的剑桥认知测验评分(P=0.049)以及痴呆家族史的存在(P=0.012,χ²(1)=8.84)与临床状况的恶化相关。此外,认知缺陷,如理解、近期记忆和执行功能评分较低,与更差的临床结局相关。
确定疾病进展更快的预测因素具有重要的临床意义,使临床医生能够估计预后并相应地规划患者护理。